Inflammatory bowel disease (IBD) research at Mayo Clinic

Mayo Clinic gastroenterologist William A. Faubion Jr., M.D., discusses how ongoing IBD research and harnessing the power of artificial intelligence (AI) and machine learning (ML) offer tremendous applications in understanding disease patterns, predictive modeling and targeting therapeutic interventions. At Mayo Clinic, we are on the forefront of applying these technologies and developing new treatments to benefit patients with IBD.


April 9, 2021

Created by

Mayo Clinic

Related Presenters

William Faubion, Jr., MD

William Faubion, Jr., MD

Dr. William Faubion is a dual certified specialist in pediatric and adult Gastroenterology with a focused interest in IBD, having nearly 20 years of experience in GI and IBD related ailments. Dr. Faubion focuses on complex disease and ...

View full profile